School of Health Sciences and Social Work, University of Portsmouth, James Watson West, 2 King Richard 1st road, Portsmouth, PO1 2FR, UK.
Poole Hospital NHS Trust, Longfleet road, Poole, BH15 2JB, UK.
Surg Endosc. 2018 Aug;32(8):3486-3494. doi: 10.1007/s00464-018-6068-5. Epub 2018 Jan 23.
As obesity becomes more prevalent, it presents a technical challenge for minimally invasive colorectal resection surgery. Various studies have examined the clinical outcomes of obese surgical patients. However, morbidly obese patients (BMI ≥ 35) are becoming increasingly more common. This study aims to investigate the short-term surgical outcomes of morbidly obese patients undergoing minimal-invasive colorectal surgery and compare them with both obese (30 ≤ BMI < 35) and non-obese patients (BMI < 30).
Patients from three centres who received minimally invasive colorectal surgical resections between 2006 and 2016 were identified from prospectively collected databases. The baseline characteristics and surgical outcomes of morbidly obese, obese and non-obese patients were analysed.
A total of 1386 patients were identified, 84 (6%) morbidly obese, 246 (18%) obese and 1056 (76%) non-obese. Patients' baseline characteristics were similar for age, operating surgeon, surgical approach but differed in terms of ASA grade and gender. There was no difference in conversion rate, length of stay, anastomotic leak rate and 30-day readmission, reoperation and mortality rates. Operation time and blood loss were different across the 3 groups (morbidly obese vs obese vs non-obese: 185 vs 188 vs 170 min, p = 0.000; 20 vs 20 vs 10 ml, p = 0.003). In patients with malignant disease there was no difference in lymph node yield or R0 clearance. Univariate and multivariate linear regression analysis showed that for every one-unit increase in BMI operative time increases by roughly 2 min (univariate 2.243, 95% CI 1.524-2.962; multivariate 2.295; 95% CI 1.554-3.036). Univariate and multivariate binary logistic regression analyses showed that BMI does not affect conversion or morbidity and mortality.
The increased technical difficulty encountered in obese and morbidly obese patients in minimally invasive colorectal surgery results in higher operative times and blood loss, although this is not clinically significant. However, conversion rate and post-operative short-term outcomes are similar between morbidly obese, obese and non-obese patients.
随着肥胖症的日益普遍,微创结直肠切除术面临着技术挑战。已有多项研究探讨了肥胖手术患者的临床结局。然而,病态肥胖患者(BMI≥35)越来越常见。本研究旨在探讨微创结直肠手术中病态肥胖患者的短期手术结局,并与肥胖(30≤BMI<35)和非肥胖患者(BMI<30)进行比较。
从前瞻性收集的数据库中确定了 2006 年至 2016 年期间接受微创结直肠手术的三个中心的患者。分析了病态肥胖、肥胖和非肥胖患者的基线特征和手术结局。
共确定了 1386 例患者,其中 84 例(6%)为病态肥胖,246 例(18%)为肥胖,1056 例(76%)为非肥胖。患者的年龄、手术医生、手术方式等基线特征相似,但 ASA 分级和性别存在差异。转换率、住院时间、吻合口漏率、30 天再入院率、再手术率和死亡率无差异。手术时间和出血量在 3 组之间存在差异(病态肥胖与肥胖与非肥胖:185 与 188 与 170 分钟,p=0.000;20 与 20 与 10 毫升,p=0.003)。在患有恶性疾病的患者中,淋巴结产量或 R0 清除率无差异。单因素和多因素线性回归分析显示,BMI 每增加 1 个单位,手术时间增加约 2 分钟(单因素 2.243,95%CI 1.524-2.962;多因素 2.295;95%CI 1.554-3.036)。单因素和多因素二项逻辑回归分析显示,BMI 不影响转换率或发病率和死亡率。
微创结直肠手术中肥胖和病态肥胖患者遇到的技术难度增加导致手术时间和出血量增加,尽管这在临床上并不重要。然而,病态肥胖、肥胖和非肥胖患者的转换率和术后短期结局相似。